Mechanisms of Hyperhomocysteinemia Induced Skeletal Muscle Myopathy after Ischemia in the CBS−/+ Mouse Model
Open Access
- 6 January 2015
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (1) , 1252-1265
Abstract
Although hyperhomocysteinemia (HHcy) elicits lower than normal body weights and skeletal muscle weakness, the mechanisms remain unclear. Despite the fact that HHcy-mediated enhancement in ROS and consequent damage to regulators of different cellular processes is relatively well established in other organs, the nature of such events is unknown in skeletal muscles. Previously, we reported that HHcy attenuation of PGC-1α and HIF-1α levels enhanced the likelihood of muscle atrophy and declined function after ischemia. In the current study, we examined muscle levels of homocysteine (Hcy) metabolizing enzymes, anti-oxidant capacity and focused on protein modifications that might compromise PGC-1α function during ischemic angiogenesis. Although skeletal muscles express the key enzyme (MTHFR) that participates in re-methylation of Hcy into methionine, lack of trans-sulfuration enzymes (CBS and CSE) make skeletal muscles more susceptible to the HHcy-induced myopathy. Our study indicates that elevated Hcy levels in the CBS−/+ mouse skeletal muscles caused diminished anti-oxidant capacity and contributed to enhanced total protein as well as PGC-1α specific nitrotyrosylation after ischemia. Furthermore, in the presence of NO donor SNP, either homocysteine (Hcy) or its cyclized version, Hcy thiolactone, not only increased PGC-1α specific protein nitrotyrosylation but also reduced its association with PPARγ in C2C12 cells. Altogether these results suggest that HHcy exerts its myopathic effects via reduction of the PGC-1/PPARγ axis after ischemia.Keywords
This publication has 34 references indexed in Scilit:
- Defective Homocysteine Metabolism: Potential Implications for Skeletal Muscle MalfunctionInternational Journal of Molecular Sciences, 2013
- Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemiaAmerican Journal of Physiology-Cell Physiology, 2012
- High bone concentrations of homocysteine are associated with altered bone morphology in humansBritish Journal of Nutrition, 2011
- SUMOylation Attenuates the Function of PGC-1αJournal of Biological Chemistry, 2009
- Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic miceMolecular and Cellular Biochemistry, 2009
- Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalkJournal of Clinical Investigation, 2007
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences, 2007
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcriptionProceedings of the National Academy of Sciences, 2006
- HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Increased Superoxide Production in Coronary Arteries in HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2003